Screener
TG Therapeutics TGTX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Short-term investment securities | 69,673 | 62,822 |
| Accounts receivable, net | 401,565 | 305,628 |
| Inventories | 147,973 | 125,586 |
| Other current assets | 43,901 | 57,580 |
| Total current assets | 1,145,687 | 630,764 |
| Restricted cash | 1,364 | 1,342 |
| Long-term investment securities | 64,368 | 59,136 |
| Right of use assets | 7,085 | 6,278 |
Document
FAQ
- What is TG Therapeutics's prepaid & other current?
- TG Therapeutics (TGTX) reported prepaid & other current of $43.9M in Q2 2026.
- How has TG Therapeutics's prepaid & other current changed year-over-year?
- TG Therapeutics's prepaid & other current increased by 73.0% year-over-year, from $25.37M to $43.9M.
- What is the long-term trend for TG Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), TG Therapeutics's prepaid & other current has grown at a 121.4% compound annual growth rate (CAGR), from $1.08M to $57.58M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about TG Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude